BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 9529618)

  • 1. New insights into polycystic kidney disease and its treatment.
    Torres VE
    Curr Opin Nephrol Hypertens; 1998 Mar; 7(2):159-69. PubMed ID: 9529618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current advances in molecular genetics of autosomal-dominant polycystic kidney disease.
    Wu G
    Curr Opin Nephrol Hypertens; 2001 Jan; 10(1):23-31. PubMed ID: 11195048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of PKD1 and PKD2 Somatic Variants in Autosomal Dominant Polycystic Kidney Cyst Epithelial Cells by Whole-Genome Sequencing.
    Zhang Z; Bai H; Blumenfeld J; Ramnauth AB; Barash I; Prince M; Tan AY; Michaeel A; Liu G; Chicos I; Rennert L; Giannakopoulos S; Larbi K; Hughes S; Salvatore SP; Robinson BD; Kapur S; Rennert H
    J Am Soc Nephrol; 2021 Dec; 32(12):3114-3129. PubMed ID: 34716216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The genetics and physiology of polycystic kidney disease.
    Calvet JP; Grantham JJ
    Semin Nephrol; 2001 Mar; 21(2):107-23. PubMed ID: 11245774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autosomal dominant polycystic kidney disease: clues to pathogenesis.
    Harris PC
    Hum Mol Genet; 1999; 8(10):1861-6. PubMed ID: 10469838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations of the human polycystic kidney disease 2 (PKD2) gene.
    Deltas CC
    Hum Mutat; 2001; 18(1):13-24. PubMed ID: 11438989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetics of polycystic kidney disease.
    Calvet JP
    J Nephrol; 1998; 11(1):24-34. PubMed ID: 9561482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coordinate expression of the autosomal dominant polycystic kidney disease proteins, polycystin-2 and polycystin-1, in normal and cystic tissue.
    Ong AC; Ward CJ; Butler RJ; Biddolph S; Bowker C; Torra R; Pei Y; Harris PC
    Am J Pathol; 1999 Jun; 154(6):1721-9. PubMed ID: 10362797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The etiology, pathogenesis, and treatment of autosomal dominant polycystic kidney disease: recent advances.
    Grantham JJ
    Am J Kidney Dis; 1996 Dec; 28(6):788-803. PubMed ID: 8957030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathogenesis of autosomal dominant polycystic kidney disease: an update.
    Somlo S; Markowitz GS
    Curr Opin Nephrol Hypertens; 2000 Jul; 9(4):385-94. PubMed ID: 10926175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genes homologous to the autosomal dominant polycystic kidney disease genes (PKD1 and PKD2).
    Veldhuisen B; Spruit L; Dauwerse HG; Breuning MH; Peters DJ
    Eur J Hum Genet; 1999 Dec; 7(8):860-72. PubMed ID: 10602361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trans-heterozygous Pkd1 and Pkd2 mutations modify expression of polycystic kidney disease.
    Wu G; Tian X; Nishimura S; Markowitz GS; D'Agati V; Park JH; Yao L; Li L; Geng L; Zhao H; Edelmann W; Somlo S
    Hum Mol Genet; 2002 Aug; 11(16):1845-54. PubMed ID: 12140187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis of polycystic kidney disease: PKD1, PKD2 and PKHD1.
    Harris PC
    Curr Opin Nephrol Hypertens; 2002 May; 11(3):309-14. PubMed ID: 11981261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pkd1 inactivation induced in adulthood produces focal cystic disease.
    Takakura A; Contrino L; Beck AW; Zhou J
    J Am Soc Nephrol; 2008 Dec; 19(12):2351-63. PubMed ID: 18776127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis of autosomal-dominant polycystic kidney disease.
    Gallagher AR; Hidaka S; Gretz N; Witzgall R
    Cell Mol Life Sci; 2002 Apr; 59(4):682-93. PubMed ID: 12022474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in the understanding of polycystic kidney disease.
    Bacallao RL; Carone FA
    Curr Opin Nephrol Hypertens; 1997 Jul; 6(4):377-83. PubMed ID: 9263688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive development of polycystic kidney disease in the mouse model expressing Pkd1 extracellular domain.
    Kurbegovic A; Trudel M
    Hum Mol Genet; 2013 Jun; 22(12):2361-75. PubMed ID: 23439951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autosomal dominant polycystic kidney disease (ADPKD, MIM 173900, PKD1 and PKD2 genes, protein products known as polycystin-1 and polycystin-2).
    Boucher C; Sandford R
    Eur J Hum Genet; 2004 May; 12(5):347-54. PubMed ID: 14872199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of PKD1 and PKD2 transcripts and proteins in human embryo and during normal kidney development.
    Chauvet V; Qian F; Boute N; Cai Y; Phakdeekitacharoen B; Onuchic LF; AttiƩ-Bitach T; Guicharnaud L; Devuyst O; Germino GG; Gubler MC
    Am J Pathol; 2002 Mar; 160(3):973-83. PubMed ID: 11891195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lowering of Pkd1 expression is sufficient to cause polycystic kidney disease.
    Lantinga-van Leeuwen IS; Dauwerse JG; Baelde HJ; Leonhard WN; van de Wal A; Ward CJ; Verbeek S; Deruiter MC; Breuning MH; de Heer E; Peters DJ
    Hum Mol Genet; 2004 Dec; 13(24):3069-77. PubMed ID: 15496422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.